@ShahidNShah

The Wolverine peptide stack is a blend of two peptides, BPC-157 and TB-500, combined in a single vial. It is named after the comic-book hero who heals from almost anything, a nod to what both peptides are studied for: repair of tendons, ligaments, muscle and other tissue. The usual versions hold 5 mg of each or 10 mg of each.
It has become one of the most searched peptide names online, mostly among athletes, lifters and anyone nursing a slow injury. Here is what each half does, how the two differ, and why they end up in the same vial.
A “stack” is two or more peptides combined so they can be used together. The Wolverine stack is the simplest one there is: BPC-157 plus TB-500 in equal amounts, freeze-dried together so every vial carries the same one-to-one ratio.
The pairing is not random. Both peptides are linked to healing, but they come at it from different directions, and that is the whole case for combining them.
| Ingredient | Amount per vial | What it is | What it has been studied for |
|---|---|---|---|
| BPC-157 | 5 mg or 10 mg | A 15-amino-acid synthetic peptide based on a protein in gastric juice | Tendon, ligament, muscle and gut repair, plus new blood vessel growth |
| TB-500 | 5 mg or 10 mg | A synthetic peptide related to thymosin beta-4, a repair protein found in almost every cell | Cell movement into damaged tissue, wound and heart repair |
| Total | 10 mg or 20 mg |
BPC stands for “body protection compound.” BPC-157 is a chain of 15 amino acids whose sequence comes from a protein in human gastric juice. Most of the research on it comes from a group in Zagreb, Croatia, which has published on it for three decades.
In rats, BPC-157 has been studied for healing torn tendons, damaged ligaments, crushed muscle and an injured gut lining. One recurring finding is that it encourages new blood vessels to form around an injury, which brings in the blood supply that tendons and ligaments usually lack. A 2014 study found it increased growth hormone receptors in tendon cells, one possible reason those cells repaired faster.
The catch is the human evidence. Beyond a handful of small reports, BPC-157 has not been through proper clinical trials.
TB-500 is a lab-made peptide based on thymosin beta-4, a protein found in almost every cell in the body. Thymosin beta-4’s main job is managing actin, the protein cells use to change shape and move. When tissue is damaged, that movement is how repair cells reach the injury.
Research on thymosin beta-4 covers wound healing, corneal repair and, in a 2004 Nature study, repair of heart tissue in mice after a heart attack. TB-500 itself became well known in horse racing, where trainers used it for recovery, before it spread into human sports and wellness circles. Like BPC-157, most of what is known comes from animals and cells.
The Wolverine stack pairs BPC-157 and TB-500, usually 5 mg or 10 mg of each.
| BPC-157 | TB-500 | |
|---|---|---|
| Based on | A protein in gastric juice | Thymosin beta-4, a repair protein in almost every cell |
| Size | 15 amino acids | Related to a 43-amino-acid protein, thymosin beta-4 |
| Main focus in research | Local repair: tendons, ligaments, gut, blood vessel growth | Getting repair cells to move: wounds, muscle, heart |
| Best-known effect | New blood vessels around an injury | Cell movement and tissue remodeling |
| Evidence | Mostly rat studies, a few small human reports | Mostly animal and cell studies |
| Banned in sport | Yes (WADA) | Yes (WADA) |
The short version: BPC-157 is linked to rebuilding the site of an injury, especially its blood supply, while TB-500 is linked to getting the repair crew there. One works on the ground, the other on logistics.
The logic of the Wolverine stack is coverage. BPC-157’s research leans toward specific tissues and the gut, and TB-500’s toward cell movement throughout the body. Put together, the idea is that one helps build the repair site while the other helps fill it.
There is also a practical reason. Plenty of buyers want both, and a single pre-mixed vial with a fixed ratio is simpler than two. That convenience is a big part of why “Wolverine” became a product name rather than just a forum nickname.
What nobody has done is test the pair together in a published clinical trial. The case for the stack is built from separate research on each half.
The benefits people associate with the Wolverine stack trace back to the individual studies. For BPC-157, that means faster tendon and ligament healing, better blood flow to injured tissue and gut protection, mostly in rats. For TB-500, it means faster wound closure, better cell migration and tissue remodeling, mostly in animals and cell cultures.
That is why the Wolverine stack draws people dealing with sports injuries, tendon problems and slow recovery from training. It is also why claims of specific results deserve caution. The animal data are interesting, but the human data are thin.
Because neither peptide has been through full clinical trials, there is no established side-effect profile for BPC-157, for TB-500, or for the two together. User reports are anecdotal and inconsistent. Neither is an FDA-approved drug.
Athletes have a simpler answer: both BPC-157 and TB-500 are on the World Anti-Doping Agency’s prohibited list, so the Wolverine stack is off limits for anyone tested in competition.
Quality also varies a lot between sellers. A blend is only as good as the two powders that went into it, so it is worth buying from a supplier that publishes lab results for each batch. For a sharper look at how much remains unproven, Medigy has covered the BPC-157 evidence gap in detail.
The Wolverine stack is sold as a single vial of freeze-dried powder, usually in a 5/5 mg or 10/10 mg size. Astral’s Wolverine peptide comes in both sizes. For anyone who wants the halves separately, the TB-500 peptide is also sold on its own in a 10 mg vial.
“Wolverine peptide” is the common name for a blend of BPC-157 and TB-500, usually 5 mg or 10 mg of each in one vial. It is not a single molecule.
It is named after the comic-book character known for healing from almost any injury, a reference to what BPC-157 and TB-500 are both studied for.
They do different things. BPC-157 is studied mostly for local repair and blood vessel growth, TB-500 for moving repair cells into damaged tissue. That difference is why they are often combined.
No. GLOW contains the same BPC-157 and TB-500 plus 50 mg of GHK-Cu, a copper peptide aimed at skin. The Wolverine stack is just the two repair peptides.
No. Neither BPC-157 nor TB-500 is an FDA-approved drug.
Yes. Both BPC-157 and TB-500 are on the World Anti-Doping Agency’s prohibited list.
The Wolverine stack pairs the two best-known repair peptides, one tied to rebuilding an injury site and the other to getting repair cells there. The individual research is real and often striking in animals. The combination itself still has no clinical trial behind it, which is worth keeping in mind next to the name.
Medical innovation is transforming healthcare in ways that extend far beyond new treatments and sophisticated equipment. Hospitals increasingly rely on digital records, remote monitoring, advanced …
Posted Nov 5, 2026 Hospitals, Special Health Technology
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2026 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 7, 2026 at 5:05am